Search This Blog

Thursday, October 31, 2019

Analyst actions, Oct. 31

Amarin (NASDAQ:AMRN) initiated with with Buy rating at Aegis. Shares up 1% premarket.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) upgraded to Buy at Gabelli. Shares up 11% premarket.
PerkinElmer (NYSE:PKI) downgraded to Neutral with an $89 (1% upside) price target at Piper Jaffray.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)